Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1

被引:550
|
作者
Schreiber, V
Amé, JC
Dollé, P
Schultz, I
Rinaldi, B
Fraulob, V
Ménissier-de Murcia, J
de Murcia, G
机构
[1] Univ Strasbourg 1, Ecole Super Biotechnol Strasbourg, CEA, Lab Convent,CNRS,UPR 9003, F-67400 Illkirch Graffenstaden, France
[2] Coll France, ULP, CNRS, INSERM,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France
关键词
D O I
10.1074/jbc.M202390200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The DNA damage dependence of poly(ADP-ribose) polymerase-2 (PARP-2) activity is suggestive of its implication in genome surveillance and protection. Here we show that the PARP-2 gene, mainly expressed in actively dividing tissues follows, but to a smaller extent, that of PARP-1 during mouse development. We found that PARP-2 and PARP-1 homo- and heterodimerize; the interacting interfaces, sites of reciprocal modification, have been mapped. PARP-2 was also found to interact with three other proteins involved in the base excision repair pathway: x-ray cross complementing factor 1 (XRCC1), DNA polymerase beta, and DNA ligase M, already known as partners of PARP-1. XRCC1 negatively regulates PARP-2 activity, as it does for PARP-1, while being a polymer acceptor for both PARP-1 and PARP-2. To gain insight into the physiological role of PARP-2 in response to genotoxic stress, we developed by gene disruption mice deficient in PARP-2. Following treatment by the alkylating agent N-nitroso-N-methylurea (MNU), PARP-2-deficient cells displayed an important delay in DNA strand breaks resealing, similar to that observed in PARP-1 deficient cells, thus confirming that PARP-2 is also an active player in base excision repair despite its low capacity to synthesize ADP-ribose polymers.
引用
收藏
页码:23028 / 23036
页数:9
相关论文
共 50 条
  • [1] Poly(ADP-ribose) polymerase-1 (PARP-1) is required in murine cell lines for base excision repair of oxidative DNA damage in the absence of DNA polymerase β
    Le Page, F
    Schreiber, V
    Dhérin, C
    de Murcia, G
    Boiteux, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) : 18471 - 18477
  • [2] Dissecting the roles of PARP-1, PARP-2 and PARG in modulating the cell death signal poly(ADP-ribose)
    Blenn, C.
    Cohausz, O.
    Malanga, M.
    Althaus, F. R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 85 - 85
  • [3] Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage
    Moroni, Flavio
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) : 96 - 103
  • [4] PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase
    Amé, JC
    Rolli, V
    Schreiber, V
    Niedergang, C
    Apiou, F
    Decker, P
    Muller, S
    Hoger, T
    Murcia, JMD
    de Murcia, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17860 - 17868
  • [5] Poly ADP-Ribose polymerase (PARP-1) and DNA damage in pulmonary arterial hypertension
    Meloche, Jolyane
    Courboulin, Audrey
    Krietsch, Jana
    Margaillan, Guillaume
    Courchesne, Antony
    Coulombe, Yan
    Provencher, Steeve
    Poirier, Guy
    Masson, Jean-Yves
    Bonnet, Sebastien
    FASEB JOURNAL, 2013, 27
  • [6] Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis
    Tentori, Lucio
    Lacal, Pedro Miguel
    Muzi, Alessia
    Dorio, Annalisa Susanna
    Leonetti, Carlo
    Scarsella, Marco
    Ruffini, Federica
    Xu, Weizheng
    Min, Wokee
    Stoppacciaro, Antonella
    Colarossi, Cristina
    Wang, Zhao-Qi
    Zhang, Jie
    Graziani, Grazia
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (14) : 2124 - 2133
  • [7] Role of Poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases:: The therapeutic potential of PARP inhibitors
    Pacher, Pal
    Szabo, Csaba
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (03): : 235 - 260
  • [8] POLY (ADP-RIBOSE) POLYMERASE-1 (PARP-1) INDUCES TROPHOBLAST SYNCYTIALIZATION
    Pater, Justin
    Shah, Girish
    MacPhee, Daniel
    PLACENTA, 2013, 34 (09) : A16 - A16
  • [9] Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications
    Sodhi, Rupinder K.
    Singh, Nirmal
    Jaggi, Amteshwar S.
    VASCULAR PHARMACOLOGY, 2010, 53 (3-4) : 77 - 87
  • [10] The Pathogenic Role of Poly(ADP-ribose) Polymerase 1 (PARP-1) in Experimental Colitis
    Larmonier, Claire B.
    LaCasse, Collin J.
    Hill, Faihza M.
    Alizadeh, Darya
    Thurston, Robert D.
    Ghishan, Fayez K.
    Kiela, Pawel R.
    GASTROENTEROLOGY, 2012, 142 (05) : S885 - S886